Patent · US Active

HCMV vaccine strain

US11591373B2 · kind B2 · utility

0Cited by

1References

23Claims

0Family size

Assignee

Universitätsmedizin der Johannes Gutenberg-Universität Mainz · DE

Inventors

Bodo Plachter · Wörrstadt, DE
Christine Zimmermann · Wiesbaden, DE

Key dates

Filing date	Jun 28, 2019
Grant date	Feb 28, 2023
Priority date	—
Expiry date	Jun 28, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/16152
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to nucleic acid molecules encoding a recombinant human cytomegalovirus (HCMV) strain, dense bodies produced by said HCMV strain and preparations of said dense bodies for use in medicine, particularly as a vaccine against HCMV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.